A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls

References

• Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 2001; 276(26)24232–24241
   PubMedGoogle Scholar
• Blake DJ, Kroger S. The neurobiology of duchenne muscular dystrophy: learning lessons from muscle?. Trends Neurosci 2000; 23(3)92–99
   PubMedGoogle Scholar
• Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002; 82(2)291–329
   PubMed Web of Science ®Google Scholar
• Boyer P, Phillips JL, Rousseau FL, Ilivitsky S. Hippocampal abnormalities and memory deficits: new evidence of a strong pathophysiological link in schizophrenia. Brain Res Rev 2007; 54(1)92–112
   PubMedGoogle Scholar
• Braff DL, Freedman R, Schork NJ, Gottesman II. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 2007; 33(1)21–32
   PubMed Web of Science ®Google Scholar
• Burdick KE, Lencz T, Funke B, Finn CT, Szeszko PR, Kane JM, et al. Genetic variation in DTNBP1 influences general cognitive ability. Hum Mol Genet 2006; 15(10)1563–1568
   PubMed Web of Science ®Google Scholar
• Burdick KE, Goldberg TE, Funke B, Bates JA, Lencz T, Kucherlapati R, et al. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr Res 2007; 89(1–3)169–172
   PubMed Web of Science ®Google Scholar
• Chiba S, Hashimoto R, Hattori S, Yohda M, Lipska B, Weinberger DR, et al. Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. J Neural Transm 2006; 113(9)1337–1346
   PubMedGoogle Scholar
• DeRosse P, Funke B, Burdick KE, Lencz T, Ekholm JM, Kane JM, et al. Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry 2006; 163(3)532–534
   PubMedGoogle Scholar
• Donohoe G, Morris DW, Clarke S, McGhee KA, Schwaiger S, Nangle JM, et al. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: A preliminary study. Neuropsychologia 2007; 45(2)454–8
   PubMedGoogle Scholar
• Fanous AH, van den Oord EJ, Riley BP, Aggen SH, Neale MC, O'Neill FA, et al. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry 2005; 162(10)1824–1832
   PubMed Web of Science ®Google Scholar
• Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, Kane JM, et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet 2004; 75(5)891–898
   PubMedGoogle Scholar
• Good P. Permutation tests. A practical guide to resampling methods for testing hypothesis. Springer-Verlag, New York 2000
   Google Scholar
• Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10(1)40–68
   PubMed Web of Science ®Google Scholar
• Hashimoto R, Hattori S, Chiba S, Yagasaki Y, Okada T, Kumamaru E, et al. Susceptibility genes for schizophrenia. Psychiatry Clin Neurosci 2006; 60 Suppl(1)S4–10
   Google Scholar
• Hattori S, Murotani T, Matsuzaki S, Ishizuka T, Kumamoto N, Takeda M, et al. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem Biophys Res Commun 2008; 373(2)298–302
   PubMed Web of Science ®Google Scholar
• Holliday EG, Handoko HY, James MR, McGrath JJ, Nertney DA, Tirupati S, et al. Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Twin Res Hum Genet 2006; 9(4)531–539
   PubMedGoogle Scholar
• Iizuka Y, Sei Y, Weinberger DR, Straub RE. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J Neurosci 2007; 27(45)12390–12395
   PubMedGoogle Scholar
• Joo EJ, Lee KY, Jeong SH, Ahn YM, Koo YJ, Kim YS. The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population. Neurosci Lett 2006; 407(2)101–106
   PubMedGoogle Scholar
• Kirov G, Ivanov D, Williams NM, Preece A, Nikolov I, Milev R, et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 2004; 55(10)971–975
   PubMedGoogle Scholar
• Kumamoto N, Matsuzaki S, Inoue K, Hattori T, Shimizu S, Hashimoto R, et al. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. Biochem Biophys Res Commun 2006; 345(2)904–909
   PubMed Web of Science ®Google Scholar
• Li T, Zhang F, Liu X, Sun X, Sham PC, Crombie C, et al. Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol Psychiatry 2005; 10(11)1037–1044
   PubMedGoogle Scholar
• Murotani T, Ishizuka T, Hattori S, Hashimoto R, Matsuzaki S, Yamatodani A. High dopamine turnover in the brains of Sandy mice. Neurosci Lett 2007; 421(1)47–51
   PubMed Web of Science ®Google Scholar
• Numakawa T, Yagasaki Y, Ishimoto T, Okada T, Suzuki T, Iwata N, et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 2004; 13(21)2699–2708
   PubMed Web of Science ®Google Scholar
• Piskulic D, Olver JS, Norman TR, Maruff P. Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review. Psychiatry Res 2007; 150(2)111–121
   PubMedGoogle Scholar
• Preston GA, Weinberger DR. Intermediate phenotypes in schizophrenia: a selective review. Dialogues Clin Neurosci 2005; 7(2)165–179
   PubMedGoogle Scholar
• Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003; 72(1)185–190
   PubMedGoogle Scholar
• Shinagawa F, Kobayashi S, Fujita K, Maekawa H. Japanese Wechsler Adult Intelligence Scale-Revised. Nihonbunkakagakusha, Tokyo 1990
   Google Scholar
• Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71(2)337–348
   PubMedGoogle Scholar
• Sugishita M. Japanese Wechsler Memory Scale-Revised. Nihonbunkakagakusha, Tokyo 2001
   Google Scholar
• Takao K, Toyama K, Nakanishi K, Hattori S, Takamura H, Takeda M, et al. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol Brain 2008; 1(1)11
   PubMedGoogle Scholar
• Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004; 113(9)1353–1363
   PubMedGoogle Scholar
• Tang JX, Zhou J, Fan JB, Li XW, Shi YY, Gu NF, et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 2003; 8(8)717–718
   PubMedGoogle Scholar
• Tochigi M, Zhang X, Ohashi J, Hibino H, Otowa T, Rogers M, et al. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci Res 2006; 56(2)154–158
   PubMedGoogle Scholar
• Toulopoulouand T, Murray RM. Verbal memory deficit in patients with schizophrenia: an important future target for treatment. Expert Rev Neurother 2004; 4(1)43–52
   PubMedGoogle Scholar
• Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S, et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 2003; 73(6)1438–1443
   PubMedGoogle Scholar
• van den Oord EJ, Sullivan PF, Jiang Y, Walsh D, O'Neill FA, Kendler KS, et al. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol Psychiatry 2003; 8(5)499–510
   PubMedGoogle Scholar
• Wechsler D. Wechsler Adult Intelligence Scale, Revised. Psychological Corporation, New York 1981
   Google Scholar
• Wechsler D. Wechsler Memory Scale Manual, Revised. Psychological Corporation, San Antonio, TX 1987
   Google Scholar
• Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, Hyde TM, et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 2004; 61(6)544–555
   PubMedGoogle Scholar
• Williams NM, Preece A, Morris DW, Spurlock G, Bray NJ, Stephens M, et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 2004; 61(4)336–344
   PubMedGoogle Scholar
• Wobrock, T, Ecker, UK, Scherk, H, Schneider-Axmann, T, Falkai, P, Gruber, O. 2008. Cognitive impairment of executive function as a core symptom of schizophrenia. World J Biol Psychiatry. 1–10.
   Google Scholar